Home » Topics » Regulatory » Patents

Patents
RSS

Potent, optically pure analogues of camptothecin designed at SCRAS

April 29, 1999

Continuing focus on PARP inhibitors at Guilford

April 29, 1999

Guilford's new PARP inhibitors potentially useful for wide variety of disorders

April 28, 1999

Tryptamine analogues as potent and selective human 5-HT2A antagonists

April 28, 1999

U.S. patent issued to NitroMed, providing protection for MED/FSAD treatment program

April 28, 1999

Inhibitors of NOS described by Pfizer

April 28, 1999

Kissei designs new series with potent and selective bronchodilating effects

April 28, 1999

Dual-action antiatherosclerotic agents in the Sankyo pipeline

April 27, 1999

New cyclic compounds designed at JT reduce only elevated blood glucose levels

April 27, 1999

Urethra-selective alpha1-agonists under development at Mitsui for urinary incontinence

April 27, 1999

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...